Add Yahoo as a preferred source to see more of our stories on Google. PH is a progressive pulmonary vascular disease estimated to affect up to 1% of the global population. Credit: Orawan ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...